Molecular Geodesics Inc.
This article was originally published in Start Up
Executive SummaryMolecular Geodesics' core patent describes biomimetic materials which posess geodesic features and stabilize through tensegrity. The company hopes to design new biocompatible and bioresorbable materials that can achive desired mechanical behaviors, incorporate bioactive molecular compounds and yet have a high strength to weight ratio.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.